For its survey, the financial portal polled 1,013 Amazon shoppers, both Prime members and non-Prime members. The survey asked respondents which products and services they would purchase under the Amazon brand.
About 37 percent of respondents said they were interested in purchasing Amazon-branded prescription drugs. This compares to about 30 percent of respondents who were interested in medical marijuana and 16 percent who said virtual physician visits.
Amazon has already debuted several private-label brands. In August, it quietly launched Basic Care, an exclusive line of 60 over-the-counter healthcare products, and in November reports surfaced that the e-commerce giant had four OTC brands.
Read the full report here.
More articles on pharmacy:
Senate committee invites 7 pharma leaders to testify at drug price hearing
4 big pharma CEOs agree to testify at February drug-pricing hearing
Walgreens pays nearly $2M to settle claims with MassHealth
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
